Conventional treatment for heart failure could attenuate the changes in up- (CPN1, and C3) and down-regulated proteins (serum albumin precursor, albumin isoform X1, IGLC, and fetuin-B) in stage C CHF. Here, IGLC1 is linked to congestive heart failure.